Theresa Pattery

1.3k total citations
38 papers, 911 citations indexed

About

Theresa Pattery is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Theresa Pattery has authored 38 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 22 papers in Virology and 8 papers in Molecular Biology. Recurrent topics in Theresa Pattery's work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (10 papers). Theresa Pattery is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (10 papers). Theresa Pattery collaborates with scholars based in Belgium, United Kingdom and United States. Theresa Pattery's co-authors include Pierre Cornélis, Monica Höfte, Kris Audenaert, Paul G. Hellewell, David H. Dockrell, Daniel G. Lee, Moira K. B. Whyte, Lucy Allen, Lee T. Bacheler and Carmen de Mendoza and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Theresa Pattery

32 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Theresa Pattery Belgium 14 327 321 282 273 88 38 911
Kun‐Wei Chan Taiwan 16 114 0.3× 235 0.7× 191 0.7× 83 0.3× 89 1.0× 45 838
Barbara Chirullo Italy 14 199 0.6× 211 0.7× 170 0.6× 42 0.2× 101 1.1× 23 670
Frans A.G. Reubsaet Netherlands 15 130 0.4× 269 0.8× 39 0.1× 55 0.2× 51 0.6× 40 735
Sunil Maherchandani India 10 309 0.9× 118 0.4× 31 0.1× 45 0.2× 33 0.4× 36 625
Mingshu Wang China 18 117 0.4× 355 1.1× 27 0.1× 53 0.2× 149 1.7× 80 882
Thomas Bruderer Switzerland 14 163 0.5× 267 0.8× 20 0.1× 161 0.6× 102 1.2× 20 1.0k
Junmin Zhu China 19 350 1.1× 448 1.4× 15 0.1× 54 0.2× 124 1.4× 26 938
Helena Barroso Portugal 15 232 0.7× 126 0.4× 319 1.1× 52 0.2× 40 0.5× 48 625
Heidi Contreras United States 11 366 1.1× 452 1.4× 18 0.1× 54 0.2× 115 1.3× 17 971

Countries citing papers authored by Theresa Pattery

Since Specialization
Citations

This map shows the geographic impact of Theresa Pattery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theresa Pattery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theresa Pattery more than expected).

Fields of papers citing papers by Theresa Pattery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theresa Pattery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theresa Pattery. The network helps show where Theresa Pattery may publish in the future.

Co-authorship network of co-authors of Theresa Pattery

This figure shows the co-authorship network connecting the top 25 collaborators of Theresa Pattery. A scholar is included among the top collaborators of Theresa Pattery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theresa Pattery. Theresa Pattery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pattery, Theresa, et al.. (2022). “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India. Frontiers in Public Health. 10. 835055–835055. 1 indexed citations
3.
Kiragga, Agnes, et al.. (2019). OP15 Use Of Digital Health Information Among HIV Populations In Uganda. International Journal of Technology Assessment in Health Care. 35(S1). 2–2. 1 indexed citations
4.
Keyaerts, Els, et al.. (2018). Comparison of the Idylla™ Respiratory (IFV-RSV) panel with the GeneXpert Xpert® Flu/RSV assay: a retrospective study with nasopharyngeal and midturbinate samples. Diagnostic Microbiology and Infectious Disease. 94(1). 33–37. 2 indexed citations
7.
Malet, Isabelle, Slim Fourati, Laurence Morand‐Joubert, et al.. (2012). Risk factors for raltegravir resistance development in clinical practice. Journal of Antimicrobial Chemotherapy. 67(10). 2494–2500. 7 indexed citations
8.
Buzón, María J., Itziar Erkizia, Christian Pou, et al.. (2011). A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors. Journal of Antimicrobial Chemotherapy. 67(1). 32–38. 6 indexed citations
9.
Houtte, Margriet Van, Gastón Picchio, Koen Van der Borght, et al.. (2009). A comparison of HIV‐1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype. Journal of Medical Virology. 81(10). 1702–1709. 25 indexed citations
10.
Poveda, Eva, Carmen de Mendoza, Theresa Pattery, et al.. (2008). Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues. AIDS. 22(17). 2395–2398. 32 indexed citations
11.
Muyldermans, Gaëtan, et al.. (2008). Reproducibility of a high-throughput HIV-1 genotypic resistance assay over time (2001–2007). Journal of the International AIDS Society. 11(Suppl 1). P205–P205. 1 indexed citations
12.
Muyldermans, Gaëtan, et al.. (2008). Reduced susceptibility to lamivudine and emtricitabine associated with the novel K66N mutation in HIV-1 reverse transcriptase. Journal of the International AIDS Society. 11(Suppl 1). P187–P187. 1 indexed citations
13.
Bradshaw, Daniel, Shazia Malik, Clare Booth, et al.. (2007). Novel Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Antimicrobial Agents and Chemotherapy. 51(12). 4489–4491. 10 indexed citations
14.
Houtte, Margriet Van, et al.. (2006). NRTI resistance associated with the RT mutation K70E in HIV-1. Antiviral Therapy. 11(5). 3 indexed citations
15.
Allen, Lucy, David H. Dockrell, Theresa Pattery, et al.. (2005). Pyocyanin Production by Pseudomonas aeruginosa Induces Neutrophil Apoptosis and Impairs Neutrophil-Mediated Host Defenses In Vivo. The Journal of Immunology. 174(6). 3643–3649. 187 indexed citations
16.
Harrigan, P. Richard, Theresa Mo, Brian Wynhoven, et al.. (2005). Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors. AIDS. 19(6). 549–554. 34 indexed citations
17.
Audenaert, Kris, Theresa Pattery, Pierre Cornélis, & Monica Höfte. (2002). Induction of Systemic Resistance toBotrytis cinereain Tomato byPseudomonas aeruginosa7NSK2: Role of Salicylic Acid, Pyochelin, and Pyocyanin. Molecular Plant-Microbe Interactions. 15(11). 1147–1156. 236 indexed citations
18.
Pattery, Theresa, et al.. (2001). Mechanisms of Pseudomonas aeruginosa induced pathogen resistance in plants. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
19.
Baysse, Christine, Sandra Matthijs, Theresa Pattery, & Pierre Cornélis. (2001). Impact of mutations inhemAandhemHgenes on pyoverdine production byPseudomonas fluorescensATCC17400. FEMS Microbiology Letters. 205(1). 57–63. 22 indexed citations
20.
Pattery, Theresa, Jean-Pierre Hernálsteens, & Henri De Greve. (1999). Identification and molecular characterization of a novel Salmonella enteritidis pathogenicity islet encoding an ABC transporter. Molecular Microbiology. 33(4). 791–805. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026